模块化 γδ TCR-T 平台:结合 KRAS pMHC 靶向与可重复给药 mRNA 衔接器重定向
A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.
92.5分
★★★★★
站内排序·非疗效
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。